Bafna Pharmaceuticals Ltd Q1FY23 profit at Rs. 1.36 crore

Bafna Pharmaceuticals Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 18.2282 crores during the period ended June 30, 2022 as compared to Rs. 16.2508 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 1.3621 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -1.0149 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.57 for the period ended June 30, 2022 as compared to Rs. -0.38 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 18.2282 crs	₹16.2508 crs	12.17%
Net Profit	₹1.3621 crs	₹-1.0149 crs	234.21%
EPS	₹0.57	₹-0.38	250.00%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 18.2282 crores during the period ended June 30, 2022 as compared to Rs.21.4286 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.1.3621 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.2.0869 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.57 for the period ended June 30, 2022 as compared to Rs.0.88 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 18.2282 crs	₹21.4286 crs	-14.94%
Net Profit	₹1.3621 crs	₹2.0869 crs	-34.73%
EPS	₹0.57	₹0.88	-35.23%

Shares of Bafna Pharmaceuticals Limited was last trading in BSE at Rs. 108.20 as compared to the previous close of Rs. 111.30. The total number of shares traded during the day was 664 in over 14 trades.

The stock hit an intraday high of Rs. 110.95 and intraday low of 106.55. The net turnover during the day was Rs. 72068.00.

Source : Equity Bulls

Keywords

BafnaPharmaceuticals Q1FY23 ResultUpdate